Go to
JCI Insight
Citations to this article
K M Argraves, … , P C Harpel, D K Strickland
Published November 1, 1997
Citation Information: J Clin Invest. 1997;100(9):2170-2181. https://doi.org/10.1172/JCI119753.
Citation Information: J Clin Invest. 1997;100(9):2170-2181. https://doi.org/10.1172/JCI119753.
Abstract
Research Article
Authors
K M Argraves, K F Kozarsky, J T Fallon, P C Harpel, D K Strickland
Total citations by year
Citation information
Citations to this article (117)
| Title and authors | Publication | Year |
|---|---|---|
|
Interaction Between Lipoprotein(a) and Other Lipid Molecules: A Review of the Current Literature
Sheashaa H, Mousa H, Abbas MT, Farina JM, Awad K, Pereyra M, Scalia IG, Ali NB, Javadi N, Bismee NN, Esfahani SA, Ibrahim O, Abdelfattah F, Ibrahim R, Abdelnabi M, Ayoub C, Arsanjani R |
Biomolecules | 2025 |
|
Functional interrogation of cellular Lp(a) uptake by genome-scale CRISPR screening
Khan TG, Cunha JB, Raut C, Burroughs M, Vyas HS, Leix K, Goonewardena SN, Smrcka AV, Speliotes EK, Emmer BT |
Atherosclerosis | 2025 |
|
Haplotype of the Lipoprotein(a) Gene Variants rs10455872 and rs3798220 Is Associated with Parameters of Coagulation, Fibrinolysis, and Inflammation in Patients after Myocardial Infarction and Highly Elevated Lipoprotein(a) Values.
Ugovšek S, Rehberger Likozar A, Levstek T, Trebušak Podkrajšek K, Zupan J, Šebeštjen M |
International journal of molecular sciences | 2024 |
|
Comparative Analysis of Atherogenic Lipoproteins L5 and Lp(a) in Atherosclerotic Cardiovascular Disease.
Akyol O, Yang CY, Woodside DG, Chiang HH, Chen CH, Gotto AM |
Current Atherosclerosis Reports | 2024 |
|
Functional interrogation of cellular Lp(a) uptake by genome-scale CRISPR screening
Khan TG, Cunha JB, Raut C, Burroughs M, Goonewardena SN, Smrcka AV, Speliotes EK, Emmer BT |
2024 | |
|
Dietary modulation of Lp(a): more questions than answers
Kris-Etherton PM, Riley TM, Petersen KS |
Journal of Lipid Research | 2024 |
|
Lipoprotein (a): Underrecognized Risk with a Promising Future
Manzato M, Wright RS, Jaffe AS, Vasile VC |
Reviews in Cardiovascular Medicine | 2024 |
|
Sortilin enhances secretion of apolipoprotein(a) through effects on apolipoprotein B secretion and promotes uptake of lipoprotein(a)
Clark JR, Gemin M, Youssef A, Marcovina SM, Prat A, Seidah NG, Hegele RA, Boffa MB, Koschinsky ML |
Journal of lipid research | 2022 |
|
Lipoprotein (a): When to Measure and How to Treat?
D Rhainds, MR Brodeur, JC Tardif |
Current Atherosclerosis Reports | 2021 |
|
Recent Updates of Lipoprotein(a) and Cardiovascular Disease
T Liu, WS Yoon, SR Lee |
Chonnam Medical Journal | 2021 |
|
Síndrome metabólico, lipoproteína(a) y aterosclerosis subclínica en población mexicana
GC Cardoso-Saldaña, M del C. González-Salazar, R Posadas-Sánchez, G Vargas-Alarcón |
Archivos de cardiologia de Mexico | 2021 |
|
Lipoprotein(a) in atherosclerosis: from pathophysiology to clinical relevance and treatment options
AR Likozar, M Zavrtanik, M Šebeštjen |
Annals of Medicine | 2020 |
|
Familial Hypercholesterolemia and Lipoprotein(a)
PP Toth |
Journal of the American College of Cardiology | 2020 |
|
Association of Serum Lipoprotein (a) Levels and Coronary Atheroma Volume by Intravascular Ultrasound
CP Huded, NP Shah, R Puri, SJ Nicholls, K Wolski, SE Nissen, L Cho |
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2020 |
|
Metabolic effects of PCSK9 inhibition with Evolocumab in subjects with elevated Lp(a)
X Zhang, LC Stiekema, ES Stroes, AK Groen |
Lipids in Health and Disease | 2020 |
|
Pragmatic Analysis of Dyslipidemia Involvement in Coronary Artery Disease: A Narrative Review
RG Mihăilă |
Current cardiology reviews | 2020 |
|
Lipoprotein(a) and its Clinical Importance
FZ avval, malihe Moammeri Salahshooh, |
2020 | |
|
Lipoprotein receptor signalling in atherosclerosis
C Mineo |
Cardiovascular Research | 2019 |
|
The VLDL receptor plays a key role in the metabolism of postprandial remnant lipoproteins
K Nakajima, Y Tokita, A Tanaka, S Takahashi |
Clinica chimica acta; international journal of clinical chemistry | 2019 |
|
New Frontiers in Lp(a)-Targeted Therapies
MJ Borrelli, A Youssef, MB Boffa, ML Koschinsky |
Trends in Pharmacological Sciences | 2019 |
|
The Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Atherosclerosis Development
A Chaulin, L Karslyan, A Aleksandrov, A Mazaev, E Grigorieva, D Nurbaltaeva |
2019 | |
|
Controlled study of the effect of proprotein convertase subtilisin-kexin type 9 inhibition with evolocumab on lipoprotein(a) particle kinetics
GF Watts, DC Chan, R Somaratne, SM Wasserman, R Scott, SM Marcovina, PH Barrett |
European Heart Journal | 2018 |
|
Atherogenic postprandial remnant lipoproteins; VLDL remnants as a causal factor in atherosclerosis
K Nakajima, A Tanaka |
Clinica chimica acta; international journal of clinical chemistry | 2018 |
|
Is Lp(a) ready for prime time use in the clinic? A pros-and-cons debate
KM Kostner, GM Kostner, AS Wierzbicki |
Atherosclerosis | 2018 |
|
Consumption of a defined, plant-based diet reduces lipoprotein(a), inflammation, and other atherogenic lipoproteins and particles within 4 weeks
RS Najjar, CE Moore, BD Montgomery |
Clinical Cardiology | 2018 |
|
Endocytosis of lipoproteins
P Zanoni, S Velagapudi, M Yalcinkaya, L Rohrer, A von Eckardstein |
Atherosclerosis | 2018 |
|
Lipoprotein (a) and Low‐density lipoprotein apolipoprotein B metabolism following apheresis in patients with elevated lipoprotein(a) and coronary artery disease
L Ma, E Waldmann, EM Ooi, DC Chan, HP Barrett, GF Watts, KG Parhofer |
European Journal of Clinical Investigation | 2018 |
|
Lipoprotein(a) catabolism: a case of multiple receptors
SP McCormick, WJ Schneider |
Pathology | 2018 |
|
Triglyceride Rich Lipoprotein -LPL-VLDL Receptor and Lp(a)-VLDL Receptor Pathways for Macrophage Foam Cell Formation
S Takahashi |
Journal of Atherosclerosis and Thrombosis | 2017 |
|
Roles of the low density lipoprotein receptor and related receptors in inhibition of lipoprotein(a) internalization by proprotein convertase subtilisin/kexin type 9
R Romagnuolo, CA Scipione, SM Marcovina, M Gemin, NG Seidah, MB Boffa, ML Koschinsky, MC Vinci |
PloS one | 2017 |
|
PCSK9 targets important for lipid metabolism
R Schulz, KD Schlüter |
Clinical Research in Cardiology Supplements | 2017 |
|
The renaissance of lipoprotein(a): Brave new world for preventive cardiology?
KL Ellis, MB Boffa, A Sahebkar, ML Koschinsky, GF Watts |
Progress in Lipid Research | 2017 |
|
Lipoprotein(a) in clinical practice: New perspectives from basic and translational science
CA Scipione, ML Koschinsky, MB Boffa |
Critical Reviews in Clinical Laboratory Sciences | 2017 |
|
Genetics of Dyslipidemia and Ischemic Heart Disease
K Sharma, RR Baliga |
Current Cardiology Reports | 2017 |
|
Vascular lesions in patient with Takayasu arteritis and massive elevated lipoprotein (a) levels. Residual involvement or premature aterosclerosis?
JC García, SR Suárez, OM Grijalvo, SG Morillo |
Clínica e Investigación en Arteriosclerosis (English Edition) | 2017 |
|
Usefulness of Lipoprotein(a) for Predicting Clinical Outcomes After Endovascular Therapy for Aortoiliac Atherosclerotic Lesions
K Hishikari, H Hikita, S Nakamura, S Nakagama, M Mizusawa, T Yamamoto, J Doi, Y Utsugi, Y Sudo, S Kimura, T Ashikaga, A Takahashi, M Isobe |
Journal of Endovascular Therapy | 2017 |
|
PCSK9 in context: A contemporary review of an important biological target for the prevention and treatment of atherosclerotic cardiovascular disease
MM Page, GF Watts |
Diabetes, obesity & metabolism | 2017 |
|
Lipoprotein(a): A missing culprit in the management of athero-thrombosis?
G Ferretti, T Bacchetti, TP Johnston, M Banach, M Pirro, A Sahebkar |
Journal of Cellular Physiology | 2017 |
|
Lesiones vasculares en paciente diagnosticada de arteritis de Takayasu y elevación masiva de lipoproteína(a). ¿Afectación residual o arterioesclerosis prematura?
JC García, SR Suárez, OM Grijalvo, SG Morillo |
Clínica e Investigación en Arteriosclerosis | 2017 |
|
PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the role of the LDL receptor
FJ Raal, RP Giugliano, MS Sabatine, MJ Koren, D Blom, NG Seidah, N Honarpour, A Lira, A Xue, P Chirovolu, S Jackson, M Di, M Peach, R Somaratne, SM Wasserman, R Scott, EA Stein |
Journal of lipid research | 2016 |
|
Lp(a) and cardiovascular risk: Investigating the hidden side of the moon
M Bucci, C Tana, MA Giamberardino, F Cipollone |
Nutrition, Metabolism and Cardiovascular Diseases | 2016 |
|
Emerging Therapeutic Options for Lowering of Lipoprotein(a): Implications for Prevention of Cardiovascular Disease
MB Boffa |
Current Atherosclerosis Reports | 2016 |
|
Lipoprotein(a) Catabolism Is Regulated by Proprotein Convertase Subtilisin/Kexin Type 9 through the Low Density Lipoprotein Receptor
R Romagnuolo, CA Scipione, MB Boffa, SM Marcovina, NG Seidah, ML Koschinsky |
The Journal of biological chemistry | 2015 |
|
How do eggs get fat? Insights into ovarian fatty acid accumulation in the shortfinned eel, Anguilla australis
EL Damsteegt, H Mizuta, N Hiramatsu, PM Lokman |
General and Comparative Endocrinology | 2015 |
|
Lipoprotein(a) hyperlipidemia as cardiovascular risk factor: pathophysiological aspects
G Schmitz, E Orsó |
Clinical Research in Cardiology Supplements | 2015 |
|
HDL-C, ABCA1-mediated cholesterol efflux, and lipoprotein(a): insights into a potential novel physiologic role of lipoprotein(a)
C Yeang, S Tsimikas |
Journal of lipid research | 2015 |
|
Lipoprotein (a) upregulates ABCA1 in liver cells via scavenger receptor-B1 through its oxidized phospholipids
M Sharma, AV Zychlinski-Kleffmann, CM Porteous, GT Jones, MJ Williams, SP McCormick |
Journal of lipid research | 2015 |
|
Tyramine and tryptamine as ligands for medical and biotechnological affinity sorbents
PA Levashov, ED Ovchinnikova, MI Afanas’eva, DA Frid, AA Az’muko, IY Adamova, SN Pokrovskii |
Russian Journal of Bioorganic Chemistry | 2015 |
|
Relationship between lipoprotein (a) and micro/macro complications in type 2 diabetes mellitus: a forgotten target
Rocio Toro, Eduardo Segura, Jesús Millan Nuñez-Cortes, Juan Carlos Pedro-Botet, Maribel Quezada-Feijoo, Alipio Mangas |
Journal of Geriatric Cardiology | 2015 |
|
Preventing in-stent restenosis using lipoprotein (a), lipid and cholesterol adsorbent materials
MR Kazemian, A Solouk, A Tan, AM Seifalian |
Medical Hypotheses | 2015 |
|
Macrophage-mediated response to hypoxia in disease
C Murdoch, S Tazzyman, J Harrison, J Yeomans, M Muthana |
Hypoxia | 2014 |
|
La lipoproteína(a) se asocia a la presencia de arteriosclerosis en pacientes con hipercolesterolemia primaria
AM Bea, R Mateo-Gallego, E Jarauta, R Villa-Pobo, P Calmarza, I Lamiquiz-Moneo, A Cenarro, F Civeira |
Clínica e Investigación en Arteriosclerosis | 2014 |
|
Lipoprotein (a): Structure, Pathophysiology and Clinical Implications
RC Maranhão, PO Carvalho, CC Strunz, F Pileggi |
Arquivos brasileiros de cardiologia | 2014 |
|
Scavenger receptor-BI is a receptor for lipoprotein(a)
XP Yang, MJ Amar, B Vaisman, AV Bocharov, TG Vishnyakova, LA Freeman, RJ Kurlander, AP Patterson, LC Becker, AT Remaley |
Journal of lipid research | 2013 |
|
Association between baseline lipoprotein (a) levels and restenosis after coronary stenting: Meta-analysis of 9 cohort studies
S Qin, J Liu, H Jiang, B Hu, Y Zhou, VM Olkkonen |
Atherosclerosis | 2013 |
|
Lipoprotein(a): a promising marker for residual cardiovascular risk assessment
A Cai, L Li, Y Zhang, Y Mo, W Mai, Y Zhou |
Disease Markers | 2013 |
|
Dissecting mannose 6-phosphate-insulin-like growth factor 2 receptor complexes that control activation and uptake of plasminogen in cells
V Leksa, K Pfisterer, G Ondrovičová, B Binder, S Lakatošová, C Donner, HB Schiller, A Zwirzitz, K Mrvová, V Pevala, E Kutejová, H Stockinger |
The Journal of biological chemistry | 2012 |
|
Lipoprotein(a) metabolism: Potential sites for therapeutic targets
J Hoover-Plow, M Huang |
Metabolism | 2012 |
|
Lipoprotein(a) particle concentration and lipoprotein(a) cholesterol assays yield discordant classification of patients defining four physiologically discrete groups
M Konerman, K Kulkarni, PP Toth, SR Jones |
Journal of Clinical Lipidology | 2012 |
|
A novel peptide derived from human apolipoprotein E is an inhibitor of tumor growth and ocular angiogenesis
PS Bhattacharjee, TS Huq, TK Mandal, RA Graves, S Muniruzzaman, C Clement, HE McFerrin, JM Hill |
PloS one | 2011 |
|
Abnormal Lipoprotein(a) Levels Predict Coronary Artery Calcification in Southeast Asians but Not in Caucasians: Use of Noninvasive Imaging for Evaluation of an Emerging Risk Factor
A Sharma, M Kasim, PH Joshi, Z Qian, E Krivitsky, K Akram, S Rinehart, G Vazquez, J Miller, MS Rohman, S Voros |
Journal of Cardiovascular Translational Research | 2011 |
|
Species differences of macrophage very low-density-lipoprotein (VLDL) receptor protein expression
S Takahashi, T Ito, Y Zenimaru, J Suzuki, I Miyamori, M Takahashi, M Takahashi, T Ishida, T Ishida, K Hirata, TT Yamamoto, T Iwasaki, H Hattori, M Shiomi |
Biochemical and Biophysical Research Communications | 2011 |
|
Evidence of dependence of lipoprotein(a) on triglyceride and high-density lipoprotein metabolism
M Konerman, K Kulkarni, PP Toth, SR Jones |
Journal of Clinical Lipidology | 2011 |
|
A Novel Peptide Derived from Human Apolipoprotein E Is an Inhibitor of Tumor Growth and Ocular Angiogenesis
PS Bhattacharjee, TS Huq, TK Mandal, RA Graves, S Muniruzzaman, C Clement, HE McFerrin, JM Hill, A Lewin |
PloS one | 2011 |
|
Lipoprotein(a): From Molecules to Therapeutics
V Bermúdez, N Arráiz, D Aparicio, E Rojas, D Gotera, X Guerra, R Canelón, J Faría, L Sorell, A Amell, N Reyna, M Cabrera, E Mengual, R Cano, C Cano, M Velasco |
American Journal of Therapeutics | 2010 |
|
Lipoprotein (a) as an Acute Phase Reactant in Patients on Chronic Hemodialysis
V Topçiu-Shufta, L Begolli, E Kryeziu |
Bosnian journal of basic medical sciences / Udruženje basičnih mediciniskih znanosti = Association of Basic Medical Sciences | 2010 |
|
Antiphospholipid antibodies and lipoprotein(a) in obese children
D Pascut, T Princi, M Donato, G Tamaro, S Parco |
Acta Paediatrica | 2009 |
|
Lipoprotein a: where are we now?
K Tziomalos, VG Athyros, AS Wierzbicki, DP Mikhailidis |
Current Opinion in Cardiology | 2009 |
|
Effects of simvastatin and carnitine versus simvastatin on lipoprotein(a) and apoprotein(a) in type 2 diabetes mellitus
F Galvano, GL Volti, M Malaguarnera, T Avitabile, T Antic, M Vacante, M Malaguarnera |
Expert Opinion on Pharmacotherapy | 2009 |
|
Therapeutic Lipidology
MH Davidson, PP Toth, KC Maki, AM Gotto |
2008 | |
|
Evidence mounts for a role of the kidney in lipoprotein(a) catabolism
JJ Albers, ML Koschinsky, SM Marcovina |
Kidney International | 2007 |
|
Regulation of cholesterol homeostasis in macrophages and consequences for atherosclerotic lesion development
M Pennings, I Meurs, D Ye, R Out, M Hoekstra, TJ van Berkel, MV Eck |
FEBS Letters | 2006 |
|
Hypoxia Regulates Macrophage Functions in Inflammation
C Murdoch, M Muthana, CE Lewis |
Journal of immunology (Baltimore, Md. : 1950) | 2005 |
|
The metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein (a) in human beings
JL Jenner, LJ Seman, JS Millar, S Lamon-Fava, FK Welty, GG Dolnikowski, SM Marcovina, AH Lichtenstein, PH Barrett, C deLuca, EJ Schaefer |
Metabolism | 2005 |
|
Apo(a) promotes thrombosis in a vascular injury model by a mechanism independent of plasminogen: Prothrombotic role of apo(a) independent of plasminogen
J SHA, B MCCULLOUGH, E HART, F NASSIR, NO Davidson, J Hoover-Plow |
Journal of Thrombosis and Haemostasis | 2005 |
|
The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor
J Ruiz, D Kouiavskaia, M Migliorini, S Robinson, EL Saenko, N Gorlatova, D Li, D Lawrence, BT Hyman, KH Weisgraber, DK Strickland |
Journal of lipid research | 2005 |
|
Deficiency of the Very Low-Density Lipoprotein (VLDL) Receptors in Streptozotocin-Induced Diabetic Rats: Insulin Dependency of the VLDL Receptor
T Iwasaki, S Takahashi, M Takahashi, Y Zenimaru, T Kujiraoka, M Ishihara, M Nagano, J Suzuki, I Miyamori, H Naiki, J Sakai, T Fujino, NE Miller, TT Yamamoto, H Hattori |
Endocrinology | 2005 |
|
The effect of estrogens and phytoestrogenic lignans on macrophage uptake of atherogenic lipoproteins
AJ Owen, M Abbey |
BioFactors | 2004 |
|
The Very Low-density Lipoprotein (VLDL) Receptor: Characterization and Functions as a Peripheral Lipoprotein Receptor
S Takahashi, J Sakai, T Fujino, H Hattori, Y Zenimaru, J Suzuki, I Miyamori, TT Yamamoto |
Journal of Atherosclerosis and Thrombosis | 2004 |
|
Metabolic and nutritional aspects of the atherogenic atypical lipoproteins: Lipoprotein(a), remnant lipoproteins, and oxidized low-density lipoprotein
WJ Castellani |
Nutrition Research | 2004 |
|
Postprandial Lipoprotein(a) Is Affected Differently by Specific Individual Dietary Fatty Acids in Healthy Young Men
T Tholstrup, S Samman |
The Journal of nutrition | 2004 |
|
Galactose-specific asialoglycoprotein receptor is involved in lipoprotein (a) catabolism
A Hrzenjak, S Frank, X Wo, Y Zhou, TV Berkel, GM Kostner |
Biochemical Journal | 2003 |
|
Lipoprotein(a) and the atherothrombotic process: Mechanistic insights and clinical implications
AM Scanu |
Current Atherosclerosis Reports | 2003 |
|
Association between small apolipoprotein(a) isoforms and frontotemporal dementia in humans
E Emanuele |
Neuroscience Letters | 2003 |
|
Lipoprotein(a): An Emerging Cardiovascular Risk Factor
G Lippi, G Guidi |
Critical Reviews in Clinical Laboratory Sciences | 2003 |
|
The Low Density Lipoprotein Receptor-related Protein Modulates Protease Activity in the Brain by Mediating the Cellular Internalization of Both Neuroserpin and Neuroserpin-Tissue-type Plasminogen Activator Complexes
A Makarova, I Mikhailenko, TH Bugge, K List, DA Lawrence, DK Strickland |
The Journal of biological chemistry | 2003 |
|
The very low density lipoprotein (VLDL) receptor--a peripheral lipoprotein receptor for remnant lipoproteins into fatty acid active tissues
Sadao Takahashi, Juro Sakai, Takahiro Fujino, Isamu Miyamori, Tokuo T Yamamoto |
Molecular and Cellular Biochemistry | 2003 |
|
Diverse roles for the LDL receptor family
DK Strickland, SL Gonias, WS Argraves |
Trends in Endocrinology & Metabolism | 2002 |
|
Studies on the plasma lipid profiles, and LCAT and CETP activities according to hyperlipoproteinemia phenotypes (HLP)
M Lee, JQ Kim, J Kim, H Oh, M Park |
Atherosclerosis | 2001 |
|
Role of various tissues in apo(a) fragmentation and excretion of fragments by the kidney
S Frank, A Hrzenjak, A Blaschitz, G Dohr, GM Kostner |
European Journal of Clinical Investigation | 2001 |
|
Expression of very low density lipoprotein receptor mRNA in circulating human monocytes: its up-regulation by hypoxia
K Nakazato, T Ishibashi, K Nagata, Y Seino, Y Wada, T Sakamoto, R Matsuoka, T Teramoto, M Sekimata, Y Homma, Y Maruyama |
Atherosclerosis | 2001 |
|
Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis
NM Caplice, C Panetta, TE Peterson, LS Kleppe, CS Mueske, GM Kostner, GJ Broze, RD Simari |
Blood | 2001 |
|
Evidence of Macrophage Foam Cell Formation by Very Low-Density Lipoprotein Receptor: Interferon-γ Inhibition of Very Low-Density Lipoprotein Receptor Expression and Foam Cell Formation in Macrophages
S Kosaka, S Takahashi, K Masamura, H Kanehara, J Sakai, Tohda, E Okada, K Oida, T Iwasaki, H Hattori, T Kodama, T Yamamoto, I Miyamori |
Circulation | 2001 |
|
The Structure of Lipoprotein(a) and Ligand-Induced Conformational Changes
JW Weisel, C Nagaswami, JL Woodhead, AA Higazi, WJ Cain, SM Marcovina, ML Koschinsky, DB Cines, K Bdeir |
Biochemistry | 2001 |
|
Isolation, quantitation, and characterization of a stable complex formed by Lp[a] binding to triglyceride-rich lipoproteins
JW Gaubatz, RC Hoogeveen, AS Hoffman, KG Ghazzaly, HJ Pownall, J Guevara, ML Koschinsky, JD Morrisett |
Journal of lipid research | 2001 |
|
Association between triglyceride-rich lipoprotein remnant receptor polymorphisms and lipid traits
J Song |
Clinical Biochemistry | 2000 |
|
Effect of Meat Replacement by Tofu on CHD Risk Factors Including Copper Induced LDL Oxidation
EL Ashton, FS Dalais, MJ Ball |
Journal of the American College of Nutrition | 2000 |
|
Interactions between apolipoprotein E and apolipoprotein(a) in patients with late-onset Alzheimer disease
V Mooser, N Helbecque, J Miklossy, SM Marcovina, P Nicod, P Amouyel |
Annals of internal medicine | 2000 |
|
Involvement of the [uPAR:uPA:PAI-1:LRP] Complex in Human Myogenic Cell Motility
B Chazaud, S Bonavaud, A Plonquet, M Pouchelet, RK Gherardi, G Barlovatz-Meimon |
Experimental Cell Research | 2000 |
|
Defects of the LDL receptor in WHHL transgenic rabbits lead to a marked accumulation of plasma lipoprotein[a]
J Fan, M Challah, H Shimoyamada, M Shiomi, S Marcovina, T Watanabe |
Journal of lipid research | 2000 |
|
Lipoprotein(a)
HH Hobbs, AL White |
Current Opinion in Lipidology | 1999 |
|
THE MAMMALIAN LOW-DENSITY LIPOPROTEIN RECEPTOR FAMILY
MM Hussain, DK Strickland, A Bakillah |
Annual Review of Nutrition | 1999 |
|
Dietary and genetic interactions in the regulation of plasma lipoprotein(a)
L Puckey, B Knight |
Current Opinion in Lipidology | 1999 |
|
Mouse very low-density lipoprotein receptor (VLDLR): gene structure, tissue-specific expression and dietary and developmental regulation
O Tiebel, K Oka, K Robinson, M Sullivan, J Martinez, M Nakamuta, K Ishimura-Oka, L Chan |
Atherosclerosis | 1999 |
|
The role of O-linked sugars in determining the very low density lipoprotein receptor stability or release from the cell
J Magrané, RP Casaroli-Marano, M Reina, M Gåfvels, S Vilaró |
FEBS Letters | 1999 |
|
Macrophage Metalloelastase, MMP-12, Cleaves Human Apolipoprotein(a) in the Linker Region between Kringles IV-4 and IV-5: POTENTIAL RELEVANCE TO LIPOPROTEIN(a) BIOLOGY
C Edelstein, SD Shapiro, O Klezovitch, AM Scanu |
The Journal of biological chemistry | 1999 |
|
Ligand Binding Properties of the Very Low Density Lipoprotein Receptor: ABSENCE OF THE THIRD COMPLEMENT-TYPE REPEAT ENCODED BY EXON 4 IS ASSOCIATED WITH REDUCED BINDING OF Mr 40,000 RECEPTOR-ASSOCIATED PROTEIN
PM Rettenberger, K Oka, L Ellgaard, HH Petersen, A Christensen, PM Martensen, D Monard, M Etzerodt, L Chan, PA Andreasen |
The Journal of biological chemistry | 1999 |
|
Identification of Megalin/gp330 as a Receptor for Lipoprotein(a) In Vitro
A Niemeier, T Willnow, H Dieplinger, C Jacobsen, N Meyer, J Hilpert, U Beisiegel |
Arteriosclerosis, thrombosis, and vascular biology | 1999 |
|
VLDL activation of plasminogen activator inhibitor-1 (PAI-1) expression: involvement of the VLDL receptor
L Nilsson, M Gåfvels, L Musakka, K Ensler, DK Strickland, B Angelin, A Hamsten, P Eriksson |
Journal of lipid research | 1999 |
|
Functional domains of the very low density lipoprotein receptor: molecular analysis of ligand binding and acid-dependent ligand dissociation mechanisms
I Mikhailenko, W Considine, KM Argraves, D Loukinov, BT Hyman, DK Strickland |
Journal of cell science | 1999 |
|
GENETICS OF LIPOPROTEIN DISORDERS
J Davignon, J Genest |
Endocrinology & Metabolism Clinics of North America | 1998 |
|
Lipoprotein(a) and inflammation in human coronary atheroma: association with the severity of clinical presentation
G Dangas, R Mehran, PC Harpel, SK Sharma, SM Marcovina, G Dube, JA Ambrose, JT Fallon |
Journal of the American College of Cardiology | 1998 |
|
Lipoprotein(a) interactions with lipid and non-lipid risk factors in patients with early onset coronary artery disease
PN Hopkins, SC Hunt, PJ Schreiner, JH Eckfeldt, IB Borecki, CR Ellison, RR Williams, KD Siegmund |
Atherosclerosis | 1998 |
|
Expression of lipoprotein receptors in atherosclerotic lesions
TP Hiltunen, S Ylä-Herttuala |
Atherosclerosis | 1998 |
|
Ligand-receptor interactions of the low density lipoprotein receptor-related protein, a multi-ligand endocytic receptor
JG Neels, IR Horn, BM Berg, H Pannekoek, AJ Zonneveld |
Fibrinolysis and Proteolysis | 1998 |
|
Expression of adhesion molecules by Lp(a): a potential novel mechanism for its atherogenicity
S Allen, S Khan, S Tam, M Koschinsky, P Taylor, M Yacoub |
The FASEB Journal | 1998 |
|
Bovine aortic endothelial cells express a variant of the very low density lipoprotein receptor that lacks the O-linked sugar domain
J Magrané, M Reina, R Pagan, A Luna, RP Casaroli-Marano, B Angelin, M Gåfvels, S Vilaró |
Journal of lipid research | 1998 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)